Molecular genetic testing to diagnose malignant hyperthermia susceptibility

J Clin Anesth. 2008 May;20(3):161-3. doi: 10.1016/j.jclinane.2007.12.011.
No abstract available

Publication types

  • Case Reports
  • Editorial

MeSH terms

  • Child, Preschool
  • Genetic Testing*
  • Humans
  • Laryngismus / drug therapy
  • Male
  • Malignant Hyperthermia / diagnosis*
  • Malignant Hyperthermia / genetics*
  • Neuromuscular Depolarizing Agents / adverse effects
  • Neuromuscular Depolarizing Agents / therapeutic use
  • Ryanodine Receptor Calcium Release Channel / genetics
  • Strabismus / surgery
  • Succinylcholine / adverse effects
  • Succinylcholine / therapeutic use

Substances

  • Neuromuscular Depolarizing Agents
  • Ryanodine Receptor Calcium Release Channel
  • Succinylcholine